AMAL THERAPEUTICS
Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva. Amal Therapeutics was incorporated in September 2012. Amal uses its proprietary cell penetrating peptide platform to develop and progress therapeutic vaccines in oncology.
AMAL THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science Neuroscience Therapeutics
Founded:
2012-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.amaltherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
45.34 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business Microsoft Azure DNS Facebook Sharer Facebook Domain Verification GlobalSign Domain Verification Incapsula Nameshield
Current Advisors List
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Amal Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series B - Amal Therapeutics
BioMedPartners
BioMedPartners investment in Series B - Amal Therapeutics
Schroder Adveq
Schroder Adveq investment in Series B - Amal Therapeutics
3B Future Health Fund
3B Future Health Fund investment in Series B - Amal Therapeutics
VI Partners
VI Partners investment in Series B - Amal Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series B - Amal Therapeutics
Schroder Adveq
Schroder Adveq investment in Series B - Amal Therapeutics
BioMedPartners
BioMedPartners investment in Series B - Amal Therapeutics
3B Future Health Fund
3B Future Health Fund investment in Series B - Amal Therapeutics
Official Site Inspections
http://www.amaltherapeutics.com
- Host name: 45.60.65.30
- IP address: 45.60.65.30
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
